Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma - Wikidata - wikimedia - TriplyDB

Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma

Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma

http://www.wikidata.org/entity/Q24669934

about

Tall cell variant of papillary thyroid carcinoma: current evidence on clinicopathologic features and molecular biology Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer.Molecular rearrangements and morphology in thyroid cancer.BRAF(V600E) Mutation, RET/PTC1 and PAX8-PPAR Gamma Rearrangements in Follicular Epithelium Derived Thyroid Lesions - Institutional Experience and Literature Review Genetic and biological subgroups of low-stage follicular thyroid cancer Papillary thyroid carcinoma: differential diagnosis and prognostic values of its different variants: review of the literature.Drosophila Cancer Models Identify Functional Differences between Ret Fusions.Unusual thyroid tumors: a review of pathologic and molecular diagnosis.Thyroid carcinoma after Chernobyl latent period, morphology and aggressiveness.Mechanisms of Disease: molecular genetics of childhood thyroid cancers.Molecular genetics of papillary thyroid carcinoma: great expectations.Clinical features and outcome of the tall cell variant of papillary thyroid carcinoma.Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival.Radiation exposure, young age, and female gender are associated with high prevalence of RET/PTC1 and RET/PTC3 in papillary thyroid cancer: a meta-analysis Thyroid tumors: novel insights from proteomic studies.Clinical implications of molecular markers in follicular cell-derived thyroid cancer.Aggressive variants of follicular cell derived thyroid carcinoma; the so called 'real thyroid carcinomas'.Molecular diagnosis for indeterminate thyroid nodules on fine needle aspiration: advances and limitations.Genetics and epigenetics of sporadic thyroid cancer.Aggressive variants of follicular cell-derived thyroid carcinomas: a cytopathologist's perspective.Impact of pathognomonic genetic alterations on the prognosis of papillary thyroid carcinoma. ESES vienna presentation.Chronic expression of RET/PTC 3 enhances basal and insulin-stimulated PI3 kinase/AKT signaling and increases IRS-2 expression in FRTL-5 thyroid cells.Human thyroid tumours, the puzzling lessons from E7 and RET/PTC3 transgenic mice.Special types of thyroid carcinoma.Tall cell and diffuse sclerosing variants of papillary thyroid cancer: outcome and predicting value of risk stratification methods.Real-time quantitative RT-PCR identifies distinct c-RET, RET/PTC1 and RET/PTC3 expression patterns in papillary thyroid carcinoma.

P2860

Q28078437-9453CCC0-0917-4F41-A8A4-1AE65B2B09EF Q31074050-5B380FB9-A52F-4A56-8831-BA33865CAA4C Q34679424-1C8052D3-5C05-405B-8B79-E3F339666D61 Q35609167-3916C2D4-4BEA-4366-BAB3-9AC8317F217D Q35749248-3B4E0B40-A1D0-4447-AC4D-BAF108859049 Q35825451-F2C77124-9E50-4E19-8040-28920408ECE8 Q36132331-21571AA2-714A-458D-8EE9-2F11E8A725B1 Q36252185-22CB49E8-EA09-49B5-A2B7-4A9AD56A1569 Q36694181-25B6C2CB-3B4A-49DC-908D-917F5BD818F1 Q36799095-63814FB4-37C2-4618-BCAC-077BE890AA7F Q36949765-C64862EA-F086-44B6-9137-4EC33B5C84D2 Q37008016-D84FCBFD-E19E-440B-83B6-AC26CB654BCD Q37022487-7C62523F-CA6F-49D3-A0F1-A6925A5545DE Q37086109-F9A0ECA3-1F48-45D2-9B7D-1B8E5B3F631C Q37579897-89541EC8-A8BB-4427-9CC9-F9CFC41E01C9 Q37611825-AE540822-292D-46A5-BA9C-665133282041 Q38102673-DD62A47E-44BB-4D55-BA2B-2D328214C709 Q38124903-FC4082BB-59AC-44A7-A7BF-803CE25218F0 Q38128097-E3394B67-367D-4318-9CB0-1B569EE12752 Q38199071-10B61037-05DE-4A9C-9AB2-0ECE587D97A1 Q38415602-7EDF993C-CFC0-4002-B7F9-F80A7BB56213 Q40513815-6D5B15B8-2CAF-4DF4-BA51-26EAAF69A184 Q42277404-B1A563DA-1C30-4096-AEC8-995EB282479F Q48120106-14FB3D91-4C02-478C-8C18-0CBC29B9F9EC Q53279076-0AD48DA3-EC15-42C3-ACE7-2D881C89A40E Q54696015-983DB9FF-7574-4805-A9AD-600CF89F5409

P2860

Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma

http://www.wikidata.org/entity/Q24669934

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Potent mitogenicity of the RET ...... of papillary thyroid carcinoma

@ast

Potent mitogenicity of the RET ...... of papillary thyroid carcinoma

@en

Potent mitogenicity of the RET ...... of papillary thyroid carcinoma

@nl

type

label

Potent mitogenicity of the RET ...... of papillary thyroid carcinoma

@ast

Potent mitogenicity of the RET ...... of papillary thyroid carcinoma

@en

Potent mitogenicity of the RET ...... of papillary thyroid carcinoma

@nl

prefLabel

Potent mitogenicity of the RET ...... of papillary thyroid carcinoma

@ast

Potent mitogenicity of the RET ...... of papillary thyroid carcinoma

@en

Potent mitogenicity of the RET ...... of papillary thyroid carcinoma

@nl

P1433

Q24669934-A608181F-BEDF-4450-ACC7-EABCF8515FDE

P1476

Q24669934-D576ED44-EBFD-4700-8B69-0E42624D26B7

P2093

Q24669934-2A4435B3-4146-4A62-A3FD-AA7E1280BFDD

Q24669934-38B2C628-3C0B-4A9B-A5FD-23147AE40C9E

Q24669934-4331C38F-581F-448E-A2F9-4FEB693017FA

Q24669934-5201FF35-1390-4592-BF19-DD8B31F57185

Q24669934-612AF532-870C-4D25-88CE-D75DF11D6B8B

Q24669934-781677C0-6E48-41C4-989D-9A54579E5AAD

Q24669934-7C93388A-2E88-42FC-ACFD-4F586E591048

Q24669934-98C96616-E289-47BA-A3EA-9C9634AC2ABA

Q24669934-9F79295C-6CD6-4413-A771-5EF960423CB5

Q24669934-D9CC3147-B807-489A-A1F6-FB1C1D5D41E5

P2860

Q24669934-1848D0C3-FF0D-454C-B3F3-DE2F75FBA3EE

Q24669934-184E5514-9CD6-43CC-8F49-65B5A735BC84

Q24669934-35F0D54C-F751-4C86-8A5E-313ACACD405C

Q24669934-544A38C0-35F5-47B9-AF9D-92454D2F8C96

Q24669934-5E62E438-8071-48B4-BBF2-41C37175E31D

Q24669934-64064F68-52C1-4A93-AF88-79B667734AC4

Q24669934-66EC5F5D-1952-4C5B-82BA-7C18F3A228CB

Q24669934-78A46D44-1713-4E32-AA22-26BDD15FA0BE

Q24669934-79EED3AA-5593-4F6C-8ABD-95A2D9391920

Q24669934-87CFAF6B-AB83-43C1-BB1A-2BC694907115

P304

Q24669934-2ED4E77B-297E-49D1-B0CE-36A520CEE47A

P31

Q24669934-8D5A60DE-D0DE-4226-8EF7-282382902C13

P356

Q24669934-F67E1835-AC39-4E05-9FBA-8F54F70A89A7

P407

Q24669934-F9CC2B3B-38F2-4B1B-B780-FB3AC949100E

P433

Q24669934-A83F1E92-F0F0-4CFD-9754-D74A4AC02650

P478

Q24669934-7B7B71D5-18F1-402D-891D-52504BED0DBC

P50

Q24669934-91A8D18C-2DFD-4D40-AEB9-1C261CBABD1E

Q24669934-9CA2A25C-D6B7-4231-93D0-519B7A7F21D7

P577

Q24669934-FCF78FC2-615F-48F4-B717-B684AC7DDC41

P698

Q24669934-107CFFBC-927B-4519-B046-CAFDE4FE7637

P932

Q24669934-F6802769-2CBD-44A1-A320-26393E1A7429

P356

S0002-9440(10)64368-4

P1433

The American Journal of Pathology

P1476

Potent mitogenicity of the RET ...... of papillary thyroid carcinoma

@en

P2093

Aldo Pinchera

http://www.w3.org/2001/XMLSchema#string

Alfredo Fusco

http://www.w3.org/2001/XMLSchema#string

Carmen Monaco

http://www.w3.org/2001/XMLSchema#string

Francesca Carlomagno

http://www.w3.org/2001/XMLSchema#string

Furio Pacini

http://www.w3.org/2001/XMLSchema#string

Gennaro Chiappetta

http://www.w3.org/2001/XMLSchema#string

Giuliana Salvatore

http://www.w3.org/2001/XMLSchema#string

Martina Pancrazi

http://www.w3.org/2001/XMLSchema#string

Massimo Santoro

http://www.w3.org/2001/XMLSchema#string

Paolo Miccoli

http://www.w3.org/2001/XMLSchema#string

P2860

Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade

Pathomorphology of thyroid gland lesions associated with radiation exposure: the Chernobyl experience and review of the literature.

The RET proto-oncogene in human cancers.

Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.

PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.

Molecular heterogeneity of RET loss of function in Hirschsprung's disease

The RFG oligomerization domain mediates kinase activation and re-localization of the RET/PTC3 oncoprotein to the plasma membrane.

Activation of mitogen-activated protein kinase is necessary but not sufficient for proliferation of human thyroid epithelial cells induced by mutant Ras.

Concomitant activation of MEK-1 and Rac-1 increases the proliferative potential of thyroid epithelial cells, without affecting their differentiation.

Tall cell variant of papillary thyroid carcinoma: a reassessment and immunohistochemical study with comparison to the usual type of papillary carcinoma of the thyroid.

P304

247-254

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9440(10)64368-4

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

160

http://www.w3.org/2001/XMLSchema#string

P50

Riccardo Giannini

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11786418

http://www.w3.org/2001/XMLSchema#string

P932

1867131

http://www.w3.org/2001/XMLSchema#string